Lorvotuzumab
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab) ) is a humanized monoclonal antibody that binds CD56 (NCAM1) . Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1].
Product Specifications
CAS Number
[339306-30-8]
Product Name Alternative
Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)
UNSPSC
12352203
Target
ADC Antibody
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lorvotuzumab.html
Purity
99.77
Solubility
10 mM in DMSO
Smiles
[Lorvotuzumab]
Molecular Weight
(146.44 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99372/Lorvotuzumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99372/Lorvotuzumab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Human Nuclear receptor subfamily 1 group I member 2 ELISA Kit
Human Nuclear receptor subfamily 1 group I member 2 ELISA Kit
Recombinant Rat Asialoglycoprotein receptor 1 (Asgr1), partial
Recombinant Rat Asialoglycoprotein receptor 1 (Asgr1), partial
Recombinant Rat Asialoglycoprotein receptor 1 (Asgr1), partial